Compugen to Participate in Two Upcoming Investor Conferences
Provided By PR Newswire
Last update: Apr 3, 2024
HOLON, Israel, April 3, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that management will participate in the following upcoming investor conferences in April:
Read more at prnewswire.com
